Global Hyperbaric Oxygen Therapy Devices Market is forecasted to grow at a decent rate of 6.5% by 2026

Hyperbaric Oxygen Therapy (HBOT) is a non-invasive technique that is used to increase the rate of healing of damaged tissues. In this treatment, the air pressure is increased two to three times higher than the normal air pressure. Thus, the oxygen-carrying blood helps to fight bacteria and other unwanted hosts in the body by promoting healing. HBOT is used to treat wounds as a result of radiation, air bubbles in blood vessels, and many other serious infections like diabetes, venous or arterial insufficiency, crush injuries, and wounds/tissue damage caused by the late effects of radiation therapy. Presently, HBOT uses 2 types of chambers:

  • Monoplace chamber: This chamber is built for one person. It's a long, plastic tube that resembles an MRI machine. The patient slips into the chamber. It is slowly pressurized with 100% oxygen.
  • Multiplace chamber: This chamber, or room, can fit two or more people at once. The treatment is largely the same. The difference is that people breathe pure oxygen through masks or hoods.
Key Benefits of HBOT Devices

HBOT devices speed up the healing process by delivering extra oxygen to injured areas. This excess oxygen in the circulation encourages the production of white blood cells and leucocytes, which fight bacteria, as well as the secretion of stem cells, which aids in speedier healing and the restoration of normal body function. Benefits associated with these devices are:
  • Increased blood flow and circulation throughout the body.
  • Block harmful bacteria and strengthens the body’s immune system.
  • Aids in the formation of new collagen and skin cells.

Market Challenges: Hyperbaric Oxygen Therapy Devices Market

The high costs associated with the HBOT treatments which require multiple sessions, reimbursement issues, and complications after HBOT are some of the key factors which are likely to hamper the HBOT devices market growth in the coming years.

North America Leads the Adoption of Hyperbaric Oxygen Therapy Devices Market

From a geographical perspective, North America holds a higher market share of the HBOT devices market. This can be mainly attributed to the increasing preference for wound healing treatments, rising number of people engaging in adventure activities, and favorable reimbursement policies.

Competitive Landscape Analysis: Hyperbaric Oxygen Therapy Devices Market

Some of the main and emerging players operating in the hyperbaric oxygen therapy devices market are Perry Baromedical Inc., Haux-Life Support, PCCI, Fink Engineering, Sosgroup, Hearmec, OxyHealth, and Environmental Tectonics Corporation, among others.

Get Customized Research Report on Hyperbaric Oxygen Therapy Devices Market @ https://meditechinsights.com/hyperbaric-oxygen-therapy-devices-market/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more

Global Drug Discovery Software market valued at $2 billion in 2020, is projected to grow at a healthy CAGR of 14% to reach $3.5 billion by 2025

The global drug discovery software market (such as ligand-based design, structure-based design, LIMS, ELN) is driven by the increasing R&D spend and pipeline, expanding scope and scale, increasing stringency of testing and regulations, growing number and size of biotechs, need for increasing cost efficiencies and reducing time to market, and move towards web/cloud-based software. Global Drug Discovery Software Market – Niche but Fast-Growing Market The worldwide drug discovery software market is niche and growing rapidly, driven by the rising pressure on the pharma and biotech companies to cut costs in the research and preclinical stage of drug development, reduce timelines and improve transparency through deep learning software tools. “ Large players present in this segment are trying to consolidate the market by becoming a one stop shop. Moreover, companies are also considering to combine their solutions with bioinformatics and LIMS tools to have a competitive edge .” - Exe
Read more